The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”, or the “Company”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

Obstructive sleep apnea is a condition that disrupts rest, leading to symptoms such as daytime fatigue, brain fog and headaches. In the long-term, untreated sleep apnea can have serious health ...

Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81.

Inspire Medical Systems shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 72 to 81. Jim Cramer Predicts Palantir Buying Surge Tonight After Morgan ...

When a man requires three blood pressure medications and still cannot keep his hypertension under control, there is a 96% chance that he has sleep apnea. Fortunately, treatment with continuous ...

The company develops minimally invasive solutions for patients with obstructive sleep apnea ... expand Inspire’s total addressable market by causing more people with obesity to seek treatment ...

untreated apnea can also lead to neurological issues, like memory loss and cognitive decline. The lack of insurance coverage impacts not just patients but also the broader healthcare system in India.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology ...

Her work has appeared in Women's Health, SELF, Prevention, The Washington Post, and more. Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty ...